https://www.pcori.org/about/pcoris-advisory-panels/advisory-panel-clinical-effectiveness-and-decision-science-ceds/biographies-advisory-panel-clinical-effectiveness-and-decision-science-ceds
Tanawin showcases Drug U.S.E Lab’s research on the real-world effectiveness of the anti-TSLP agent, tezepelumab, in severe asthma.
Tezepelumab was effective in improving asthma exacerbations in the entire cohort, including in patients who switched from a prior biologic or who were naïve users of a respiratory biologic.
Related Posts
